Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nathalie Roxanne Javidi-Sharifi, M.D., Ph.D.

Concepts (69)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Nathalie Javidi-Sharifi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Nathalie Javidi-Sharifi has written about over time.
Receptor, Fibroblast Growth Factor, Type 3, 2 publications between 2014 and 2014, average publication date June 2014. Fibroblast Growth Factor 2, 3 publications between 2014 and 2019, average publication date August 2016. Gastrointestinal Stromal Tumors, 2 publications between 2014 and 2018, average publication date October 2016. Proto-Oncogene Proteins c-kit, 2 publications between 2014 and 2018, average publication date October 2016. Pyrimidines, 3 publications between 2014 and 2024, average publication date October 2017. Leukemia, Myeloid, Acute, 2 publications between 2016 and 2019, average publication date November 2017. Protein Kinase Inhibitors, 6 publications between 2014 and 2024, average publication date February 2018. Exosomes, 1 publications between 2019 and 2019, average publication date February 2019. Mesenchymal Stem Cells, 1 publications between 2019 and 2019, average publication date February 2019. Receptor, Fibroblast Growth Factor, Type 1, 1 publications between 2019 and 2019, average publication date February 2019. Antineoplastic Agents, 3 publications between 2014 and 2024, average publication date January 2020. Antineoplastic Combined Chemotherapy Protocols, 1 publications between 2021 and 2021, average publication date October 2021. Leukemia, Myeloid, Chronic-Phase, 1 publications between 2021 and 2021, average publication date October 2021. Niacinamide, 1 publications between 2021 and 2021, average publication date October 2021. Pyrazoles, 2 publications between 2021 and 2024, average publication date February 2023. Leukemia, Lymphocytic, Chronic, B-Cell, 1 publications between 2024 and 2024, average publication date May 2024. Piperidines, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Javidi-Sharifi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.